Site icon Drug Trials For Money – Paid Clinical Trials

Insulin Delivery With Self-Adjusting Closed-Loop and Behavioral Glycemic Control Enhanced by Prediction

Conditions: Type 1 Diabetes (T1D)
Interventions: Device: Automated Insulin Delivery (AID); Device: AIDANET + Fully Closed Loop (FCL); Device: AIDANET + Anticipatory Closed Loop (ACL)
Sponsors: Sue Brown; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Tandem Diabetes Care, Inc.; DexCom, Inc.
**RECRUITING NOW**

Source: View full study details on ClinicalTrials.gov

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. By listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.

Exit mobile version